Qitan Technology Company
Developer of a genome sequencing technology. The company takes advantage of nanopores to sequence single nucleic acid molecules.Using innovative nanopore gene sequencing technology, it provides single-molecule sequencing capability with long reading length, real-time output of sequencing results, low single-running cost, small and convenient instrument, and cost-effective gene sequencing solution without complicated library preparation. It can directly detect the apparent modification of nucleic acids and expand the application of gene sequencing technology in cutting-edge biological research and clinical medicine such as instant diagnosis, metagenomics, epigenetics, RNA and transcriptomics.
Founded Date:
1-1
Last Funding Type:
Series A
Headquarters:
China
Technology:
genetics and genomics
Employee Number:
51-100
Industry:
Biotechnology, Health Care
Last Funding Date:
43964
Funding Status:
Early Stage Venture